首页> 美国卫生研究院文献>Clinical Pediatric Endocrinology >Contiguous Xp11.4 Gene Deletion Leading to Ornithine Transcarbamylase Deficiency Detected by High-density Single-nucleotide Array
【2h】

Contiguous Xp11.4 Gene Deletion Leading to Ornithine Transcarbamylase Deficiency Detected by High-density Single-nucleotide Array

机译:通过高密度单核苷酸阵列检测到导致鸟氨酸转氨甲酰酶缺乏的连续Xp11.4基因缺失。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ornithine transcarbamylase (OTC) is one of the enzymes involved in the urea cycle. OTC deficiency, which is caused by impaired synthesis of OTC in the liver, is the most common inherited disease of urea cycle disorders. In this paper, we describe the case of an OTC-deficient Japanese boy wherein an analysis based on high-density single-nucleotide polymorphisms (SNPs) revealed the absence of the entire OTC locus and nearby genes. We identified a deletion on Xp11.4; the size of the deletion fragment was approximately 1 Mb. The deleted region included genes encoding transmembrane 4 superfamily member 2 (TSPAN7), MID1 interacting protein 1 (MID1IP1) and part of the retinitis pigmentosa GTPase regulator (RPGR) in addition to OTC. The results of a high-density SNP assay and PCR confirmed that the mother of the patient was a carrier of the mutation. Previously, determination of breakpoints for large unknown deletions was timeconsuming and laborintensive. However, the use of the widely available DNA chip technology allows for rapid determination of deletion breakpoints; therefore, it will become a standard technique in study of patients with a large genomic deletion of contiguous genes for provision of comprehensive genetic counseling and initiation of clinical management.
机译:鸟氨酸转氨甲酰酶(OTC)是参与尿素循环的酶之一。 OTC缺乏症是由肝中OTC合成受损引起的,是尿素循环障碍最常见的遗传疾病。在本文中,我们描述了一个OTC缺乏的日本男孩的情况,其中基于高密度单核苷酸多态性(SNP)的分析揭示了整个OTC基因座和附近基因的缺失。我们在Xp11.4上发现了一个缺失。缺失片段的大小约为1 Mb。除OTC外,缺失的区域还包括编码跨膜4超家族成员2(TSPAN7),MID1相互作用蛋白1(MID1IP1)和部分视网膜色素变性GTPase调节剂(RPGR)的基因。高密度SNP分析和PCR的结果证实,患者的母亲是突变的载体。以前,确定大型未知删除的断点既费时又费力。但是,使用广泛可用的DNA芯片技术可以快速确定缺失断点。因此,它将成为研究连续基因大的基因组缺失的患者的标准技术,以提供全面的遗传咨询和临床治疗管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号